Low Dose Metronomic Oral Cyclophosphamide for Hormone Resistant Prostate Cancer: A Phase II Study
To access this article, please choose from the options below
Study received approval from St. Georges Hospital Local Research Ethics Committee.
PII: S0022-5347(07)00281-9
doi:10.1016/j.juro.2007.01.143
© 2007 American Urological Association. Published by Elsevier Inc. All rights reserved.

